|
[1]
|
Stark, B.A., DeCleene, N.K., Desai, E.C., Hsu, J.M., Johnson, C.O., Lara-Castor, L., et al. (2025) Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023. JACC, 86, 2167-2243. [Google Scholar] [CrossRef]
|
|
[2]
|
Otto, C.M., Nishimura, R.A., Bonow, R.O., Carabello, B.A., Erwin, J.P., Gentile, F., et al. (2021) 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 143, e72-e227. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Praz, F., et al. (2025) 2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease. European Heart Journal, 46, 4635-4736.
|
|
[4]
|
Yamamoto, Y., Daimon, M., Nakanishi, K., Nakao, T., Hirokawa, M., Ishiwata, J., et al. (2022) Incidence of Atrial Functional Tricuspid Regurgitation and Its Correlation with Tricuspid Valvular Deformation in Patients with Persistent Atrial Fibrillation. Frontiers in Cardiovascular Medicine, 9, Article ID: 1023732. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Vîjan, A.E., Daha, I.C., Delcea, C., Bădilă, E. and Dan, G. (2022) Prognostic Impact of Severe Atrial Functional Tricuspid Regurgitation in Atrial Fibrillation Patients. Journal of Clinical Medicine, 11, Article No. 7145. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Pagnesi, M., Riccardi, M., Chiarito, M., Stolfo, D., Baldetti, L., Lombardi, C.M., et al. (2024) Characteristics and Outcomes of Patients with Tricuspid Regurgitation and Advanced Heart Failure. Journal of Cardiovascular Medicine, 25, 200-209. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Hahn, R.T. (2023) Tricuspid Regurgitation. New England Journal of Medicine, 388, 1876-1891. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Hahn, R.T., Badano, L.P., Bartko, P.E., Muraru, D., Maisano, F., Zamorano, J.L., et al. (2022) Tricuspid Regurgitation: Recent Advances in Understanding Pathophysiology, Severity Grading and Outcome. European Heart Journal—Cardiovascular Imaging, 23, 913-929. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Muraru, D., Badano, L.P., Hahn, R.T., Lang, R.M., Delgado, V., Wunderlich, N.C., et al. (2024) Atrial Secondary Tricuspid Regurgitation: Pathophysiology, Definition, Diagnosis, and Treatment. European Heart Journal, 45, 895-911. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Adamo, M., Chioncel, O., Pagnesi, M., Bayes-Genis, A., Abdelhamid, M., Anker, S.D., et al. (2024) Epidemiology, Pathophysiology, Diagnosis and Management of Chronic Right-Sided Heart Failure and Tricuspid Regurgitation. a Clinical Consensus Statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC. European Journal of Heart Failure, 26, 18-33. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Naser, J.A., Castrichini, M., Ibrahim, H.H., Scott, C.G., Lin, G., Lee, E., et al. (2024) Secondary Tricuspid Regurgitation: Incidence, Types, and Outcomes in Atrial Fibrillation vs. Sinus Rhythm. European Heart Journal, 45, 2878-2890. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Sanusi, M., Vempati, R., Umashankar, D., Tarannum, S., Varma, Y., Mohammed, F., et al. (2025) Molecular Mechanisms of Atrial Fibrillation Recurrence after Successful Catheter Ablation. Cells, 15, Article No. 36. [Google Scholar] [CrossRef]
|
|
[13]
|
Patlolla, S.H., Schaff, H.V., Nishimura, R.A., Stulak, J.M., Chamberlain, A.M., Pislaru, S.V., et al. (2022) Incidence and Burden of Tricuspid Regurgitation in Patients with Atrial Fibrillation. Journal of the American College of Cardiology, 80, 2289-2298. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Nishiwaki, S., Watanabe, S., Yoneda, F., Tanaka, M., Aizawa, T., Yamagami, S., et al. (2022) Impact of Catheter Ablation on Functional Tricuspid Regurgitation in Patients with Atrial Fibrillation. Journal of Interventional Cardiac Electrophysiology, 66, 1441-1453. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Tan, J., Yang, M., Wang, H., Shen, C., Wu, M., Xu, H., et al. (2022) Moderate Heart Rate Reduction Promotes Cardiac Regeneration through Stimulation of the Metabolic Pattern Switch. Cell Reports, 38, Article ID: 110468. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Soulat-Dufour, L., Lang, S., Addetia, K., Ederhy, S., Adavane-Scheuble, S., Chauvet-Droit, M., et al. (2022) Restoring Sinus Rhythm Reverses Cardiac Remodeling and Reduces Valvular Regurgitation in Patients with Atrial Fibrillation. Journal of the American College of Cardiology, 79, 951-961. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Liu, W., Wang, A., Li, Q., Zhang, Q., Chen, S., Wei, Y., et al. (2025) Long-Term Outcome of Catheter Ablation in Patients with Persistent Atrial Fibrillation and Functional Tricuspid Regurgitation. Frontiers in Cardiovascular Medicine, 12, Article ID: 1600238. [Google Scholar] [CrossRef]
|
|
[18]
|
Cha, M.J., Lee, S.A., Cho, M.S., et al. (2023) Reduction of Moderate to Severe Tricuspid Regurgitation after Catheter Ablation for Atrial Fibrillation. Heart, 110, 523-530. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Barison, A., Timoteo, A.T., Liga, R., Borodzicz-Jazdzyk, S., El Messaoudi, S., Luong, C., et al. (2024) Cardiovascular Imaging Research and Innovation in 2023. European Heart Journal—Imaging Methods and Practice, 2, qyae029. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
潘文志, 宋光远, 刘先宝, 等. 三尖瓣反流经导管治疗的中国专家共识[J]. 中国介入心脏病学杂志, 2024, 32(10): 551-561.
|
|
[21]
|
Rajiah, P.S., Reddy, P., Baliyan, V., Hedgire, S.S., Foley, T.A., Williamson, E.E., et al. (2023) Utility of CT and MRI in Tricuspid Valve Interventions. RadioGraphics, 43, e220153. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Latib, A., Grigioni, F. and Hahn, R.T. (2018) Tricuspid Regurgitation: What Is the Real Clinical Impact and How Often Should It Be Treated? EuroIntervention, 14, AB101-AB111. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Pype, L.L., Domenech-Ximenos, B., Paelinck, B.P., Sturkenboom, N. and Van De Heyning, C.M. (2024) Assessment of Tricuspid Regurgitation by Cardiac Magnetic Resonance Imaging: Current Role and Future Applications. Journal of Clinical Medicine, 13, Article No. 4481. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Zhang, B., Xu, H., Zhang, H., Liu, Q., Ye, Y., Hao, J., et al. (2020) Prognostic Value of N-Terminal pro-B-Type Natriuretic Peptide in Elderly Patients with Valvular Heart Disease. Journal of the American College of Cardiology, 75, 1659-1672. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Craiem, D., Moukarzel, J., Casciaro, M.E., Stipechi, V. and Guevara, E. (2025) Association between Obesity and Prevalence of Significant Regurgitant Valvular Heart Disease over Time: A Cohort Study. Obesity Research & Clinical Practice, 19, 130-137. [Google Scholar] [CrossRef] [PubMed]
|